NEW YORK, March 29, 2011 /PRNewswire/ -- BlackRock Inc.
(NYSE: BLK) will replace Genzyme Corp. (NASD: GENZ) in the S&P
500 index after the close of trading on Friday, April 1, 2011. S&P Global 1200
constituent Sanofi-aventis (NYSE: SNY) is acquiring Genzyme in a
deal expected to be completed soon, pending final conditions.
Standard & Poor's will monitor this transaction, and post
any relevant updates on its website: www.standardandpoors.com.
BlackRock is a publicly owned investment manager. Headquartered
in New York, NY, the company will
be added to the S&P 500 GICS (Global Industry Classification
Standard) Asset Management & Custody Banks Sub-Industry
index.
Following is a summary of the change:
|
S&P 500
INDEX – April 1, 2011
|
|
|
COMPANY
|
GICS
ECONOMIC SECTOR
|
GICS
SUB-INDUSTRY
|
|
|
ADDED
|
BlackRock
|
Financials
|
Asset
Management & Custody Banks
|
|
|
DELETED
|
Genzyme
|
Health
Care
|
Biotechnology
|
|
|
|
|
|
|
|
For more information about S&P Indices, please visit
www.standardandpoors.com/indices.
About S&P Indices
S&P Indices, the world's leading index provider, maintains a
wide variety of investable and benchmark indices to meet an array
of investor needs. Over $1.25
trillion is directly indexed to Standard & Poor's family
of indices, which includes the S&P 500, the world's most
followed stock market index, the S&P/Case-Shiller Home Price
Indices, the leading measure of U.S. home prices, the S&P
Global BMI, an index with approximately 11,000 constituents, the
S&P GSCI, the industry's most closely watched commodities
index, and the S&P National AMT-Free Municipal Bond Index, the
premier investable index for U.S. municipal bonds. For more
information, please visit www.standardandpoors.com/indices.
For more information contact:
David M. Blitzer, Ph.D.
Managing Director & Chairman of the Index Committee
(212) 438-3907
SOURCE Standard & Poor's